Amy E. Moran

4.2k citations

46 papers · 2.9k indexed · 4 hit papers · h-index 22

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in ⓘ

Immunology 21
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 12
- T-cell and B-cell Immunology 7
Virology 4
- HIV Research and Treatment 4

Co-authors: Kristin A. Hogquist (3 shared papers)Jennifer A. Punt (1 shared paper)Nicole R. Cunningham (1 shared paper)Yan Xing (1 shared paper)Jonathan S. Maltzman (1 shared paper)Andrew D. Weinberg (6 shared papers)Monica M. Bertagnolli (7 shared papers)Adelaide M. Carothers (6 shared papers)
Journals: The Journal of Immunology (7 papers)Cancer Research (5 papers)Journal of Clinical Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Neoplasia (1 paper)
Partner nations: United States United Kingdom Japan

In The Last Decade

Amy E. Moran

43 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Androgen receptor activity in T cells limits checkpoint blockade efficacy 2022 · 233 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature
2021 Nature Biotechnology
2012 The Journal of Immunology
2011 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Amy E. Moran

Since Specialization

Citations

This map shows the geographic impact of Amy E. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Moran more than expected).

Fields of papers citing papers by Amy E. Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Moran. The network helps show where Amy E. Moran may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy E. Moran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy E. Moran Line = papers co-authored together Amy E. Moran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse The Journal of Experimental Medicine ·Amy E. Moran, Keli L. Holzapfel, Yan Xing, Nicole R. Cunningham, Jonathan S. Maltzman, Jennifer A. Punt, Kristin A. Hogquist Hit paper breakdown →	2011	769
2	Antigen-Independent Differentiation and Maintenance of Effector-like Resident Memory T Cells in Tissues The Journal of Immunology ·Kerry A. Casey, Kathryn Fraser, Jason M. Schenkel, Amy E. Moran, Michael C. Abt, Lalit K. Beura, Philip J. Lucas, David Artis, E. John Wherry, Kristin A. Hogquist, Vaiva Vezys, David Masopust Hit paper breakdown →	2012	511
3	Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data Nature Biotechnology ·Duanchen Sun, Xiangnan Guan, Amy E. Moran, Ling‐Yun Wu, David Z. Qian, Pepper Schedin, Mu‐Shui Dai, Alexey V. Danilov, Joshi J. Alumkal, Andrew C. Adey, Paul T. Spellman, Zheng Xia Hit paper breakdown →	2021	234
4	Androgen receptor activity in T cells limits checkpoint blockade efficacy Nature ·Xiangnan Guan, Fanny Polesso, Chaojie Wang, Archana Sehrawat, Reed M. Hawkins, Susan Murray, George Thomas, Breanna Caruso, Reid F. Thompson, Mary A. Wood, Christina Hipfinger, Scott A. Hammond, Julie N. Graff, Zheng Xia, Amy E. Moran Hit paper breakdown →	2022	233
5	The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy Current Opinion in Immunology ·Amy E. Moran, Magdalena Kovacsovics-Bankowski, Andrew D. Weinberg	2013	131
6	Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice Journal of Biological Chemistry ·Amy E. Moran, Daniel H. Hunt, Sara H. Javid, Mark Redston, Adelaide M. Carothers, Monica M. Bertagnolli	2004	96
7	Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies Proceedings of the National Academy of Sciences ·Audray K. Harris, Joel R. Meyerson, Yumiko Matsuoka, Oleg Kuybeda, Amy E. Moran, Donald Bliss, Suman R. Das, Jonathan W. Yewdell, Guillermo Sapiro, Kanta Subbarao, Sriram Subramaniam	2013	88
8	A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone Journal for ImmunoTherapy of Cancer ·Julie N. Graff, Tomasz M. Beer, Joshi J. Alumkal, Rachel Slottke, William L. Redmond, George Thomas, Reid F. Thompson, Mary A. Wood, Yoshinobu Koguchi, Yiyi Chen, Emile Latour, Raymond C. Bergan, Charles G. Drake, Amy E. Moran	2020	87
9	Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse. PubMed ·Amy E. Moran, Adelaide M. Carothers, Michael J. Weyant, Mark Redston, Monica M. Bertagnolli	2005	69
10	Controlled Growth Factor Release in 3D‐Printed Hydrogels Advanced Healthcare Materials ·Pengrui Wang, David B. Berry, Amy E. Moran, Frank He, Trevor Tam, Luwen Chen, Shaochen Chen	2019	63
11	T‐cell receptor affinity in thymic development Immunology ·Amy E. Moran, Kristin A. Hogquist	2011	60
12	3D bioprinting of hydrogels for retina cell culturing Bioprinting ·Pengrui Wang, Xin Li, Wei Zhu, Zheng Zhong, Amy E. Moran, Wen‐qiu Wang, Kang Zhang, Shaochen Chen	2018	55
13	Carnosol Inhibits β-Catenin Tyrosine Phosphorylation and Prevents Adenoma Formation in the C57BL/6J/Min/+ (Min/+) Mouse Cancer Research ·Amy E. Moran, Adelaide M. Carothers, Michael J. Weyant, Mark Redston, Monica M. Bertagnolli	2005	52
14	3D Printing of a Biocompatible Double Network Elastomer with Digital Control of Mechanical Properties Advanced Functional Materials ·Pengrui Wang, David B. Berry, Zhaoqiang Song, Wisarut Kiratitanaporn, Jacob Schimelman, Amy E. Moran, Frank He, Brian Xi, Shengqiang Cai, Shaochen Chen	2020	44
15	Maturation of the HIV-1 core by a non-diffusional phase transition Nature Communications ·Gabriel A. Frank, Kedar Narayan, Julian W. Bess, Gregory Q. Del Prete, Xiongwu Wu, Amy E. Moran, Lisa M. Hartnell, Lesley A. Earl, Jeffrey D. Lifson, Sriram Subramaniam	2015	43
16	Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist Cancer Immunology Research ·Fanny Polesso, Andrew D. Weinberg, Amy E. Moran	2018	37
17	Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab) Neoplasia ·Lauren B. Peiffer, James R. White, Carli B. Jones, Rachel Slottke, Sarah E. Ernst, Amy E. Moran, Julie N. Graff, Karen S. Sfanos	2022	36
18	Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ The Journal of Immunology ·Amy E. Moran, Fanny Polesso, Andrew D. Weinberg	2016	28
19	OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function The Journal of Immunology ·Fanny Polesso, Minhaz Sarker, Andrew D. Weinberg, Susan Murray, Amy E. Moran	2019	27
20	Changes in Antitumor Response in C57BL/6J-Min/+ Mice during Long-term Administration of a Selective Cyclooxygenase-2 Inhibitor Cancer Research ·Adelaide M. Carothers, Amy E. Moran, Nancy L. Cho, Mark Redston, Monica M. Bertagnolli	2006	27

About Amy E. Moran

Amy E. Moran is a scholar working on Immunology, Virology, Oncology, Structural Biology and Process Chemistry and Technology, having authored 46 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (12 papers), Prostate Cancer Treatment and Research (8 papers), T-cell and B-cell Immunology (7 papers), CAR-T cell therapy research (6 papers), HIV Research and Treatment (4 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Immunology (1.8k citations), Oncology (880 citations), Cancer Research (204 citations), Virology (58 citations) and Molecular Biology (698 citations). Amy E. Moran has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Kristin A. Hogquist, Jennifer A. Punt, Nicole R. Cunningham, Yan Xing, Jonathan S. Maltzman, Andrew D. Weinberg, Monica M. Bertagnolli, Adelaide M. Carothers, Mark Redston and Fanny Polesso. Their work appears in journals such as The Journal of Immunology, Cancer Research, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer and Neoplasia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact